Michael M Lederman

4PUBLICATIONS
30CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nanotoxicology, health and safetyCardiology (incl. cardiovascular diseases)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 19, 2025
Interleukin-2 is a potent latency reversal agent in people with treated HIV-1.

Michael L Freeman, Brian M Clagett, Konstantin Leskov

|Mar 06, 2023
HIV post-treatment controllers have distinct immunological and virological features.

Behzad Etemad, Xiaoming Sun, Yijia Li

|Sep 25, 2020
CX3CL1 and IL-15 Promote CD8 T cell chemoattraction in HIV and in atherosclerosis.

Soumya Panigrahi, Bonnie Chen, Mike Fang

Pageof 1